IKZF1 and leukemia: We determined MRD15 and MRD33 levels to investigate if initial response to treatment contributed to leukemia recurrence in CRLF2pos/IKZF1Δ patients by analyzing blast clearance in the bone marrow of CRFL2pos patients with or without IKZF1 deletions.